Income Statement (NABRIVA/THERAPEUTICS)

NABRIVA/THERAPEUTICS NEWS

Nabriva Therapeutics (NASDAQ:NBRV) and Supernus Pharmaceuticals (NASDAQ:SUPN) Head to Head Survey By MarketBeat - 3 weeks ago

Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) and Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) are both small-cap medical companies, but which is the better business? We will compa… [+6614 chars]...

Read more
Antibiotic Collaboration and Licensing Agreements Analysis Report and Directory 2016-2025: Benchmark Deals Entered Into by the World's Leading Biopharma Companies By Research - 3 weeks ago

Dublin, June 17, 2025 (GLOBE NEWSWIRE) -- The "Antibiotic Collaboration and Licensing Deals 2016-2025" report has been added to ResearchAndMarkets.com's offering. This report contains a comprehensiv… [+11342 chars]...

Read more
Complicated Urinary Tract Infections Market Set to Experience Stunning Growth During the Forecast Period (2025–2034) | DelveInsight By DelveInsight - 4 days ago

New York, USA, July 03, 2025 (GLOBE NEWSWIRE) -- Complicated Urinary Tract Infections Market Set to Experience Stunning Growth During the Forecast Period (20252034) | DelveInsight  The growth of the… [+27175 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA
217.88 -0.75
-0.34%
CVX
148.58 1.18
0.8%
CAT
392.95 1.44
0.37%
INTC
22.37 0.37
1.68%
MSFT
496.6 -1.12
-0.23%
DIS
123.26 0.1
0.08%
DOW
28 0.52
1.87%
CSCO
68.45 -0.48
-0.7%
GS
702.65 -8.29
-1.17%